Steven P
The medication activates GLP-1 receptors in your hypothalamusthe brain region controlling hunger and satietystarting within the first 24 to 48 hours
There is no randomized trial of twice-weekly retatrutide
This work was supported by the Funds of National Natural Science Foundation of China (82060728), Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), Talents of Guizhou Science and Technology Platform [2021]1350-009, Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
The data in Table 1 reflect the exposure of 2,327 patients with type 1 diabetes to insulin glargine or NPH in Studies A, B, C, and D [see Clinical Studies (14.2)]
Understanding these stages prevents the most common mistake new users make, which is assuming the medication is not effective simply because they do not feel different yet